JETTIE LEGER: Open Payments
NPI 1659983575 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 134 payments from 20 companies in 2025. Trend: 2023 $782 · 2024 $1,372 · 2025 $2,168
Food & beverage: $2,168
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 26 | $332 |
| ABBVIE INC. | 25 | $313 |
| PFIZER INC. | 19 | $293 |
| Lilly USA, LLC | 17 | $283 |
| Amgen Inc. | 13 | $270 |
| AstraZeneca Pharmaceuticals LP | 6 | $236 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 6 | $61 |
| GlaxoSmithKline, LLC. | 3 | $46 |
Products named: MOUNJARO, REPATHA, FARXIGA, Ozempic, VRAYLAR, UBRELVY, PREVNAR 20, NURTEC ODT.
Industry payments across KS — which companies pay providers there.
